Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group. - Mouridsen,H.; Gershanovich,M.; Sun,Y.; Perez-Carrion,R.; Boni,C.; Monnier,A.; Apffelstaedt,J.; Smith,R.; Sleeboo,H.P.; Jaenicke,F.; Pluzanska,A.; Dank,M.; et al. (J Clin Oncol, 2003)